#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5760	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2598	521.3	0	.	n	.	0	C451T	SNP	451	451	C	974	974	T	681	T,C,A,G	459,172,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5760	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2598	521.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1707	1707	C	720	C,A,G	642,2,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	5760	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2598	521.3	0	HET	.	.	.	C207T,G	.	207	207	C	730	730	C	558	C,T,G	368,122,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3500	606.5	0	.	n	.	0	T695C	SNP	695	695	T	1085	1085	C	683	C,T,A	611,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3500	606.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2361	2361	C	664	C,A	606,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3500	606.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2435	2435	A	666	A,G	595,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3500	606.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2987	2987	C	691	C,A	631,6	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3500	606.5	0	HET	.	.	.	A1638G,C,T	.	1638	1638	A	2028	2028	A	657	A,G,C,T	459,145,1,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	544	folP	855	855	100.0	folP.l15.c4.ctg.1	1978	65.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1274	1276	AGC	67;67;67	A;G;C	63;64;64	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1304	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	78.6	1	SNP	p	S91F	1	.	.	271	273	TTC	883	885	TTC	101;101;102	T;T;C	88;84;92	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1304	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	78.6	1	SNP	p	D95G	1	.	.	283	285	GGC	895	897	GGC	108;108;108	G;G;C	93;95;87	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1304	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	78.6	1	SNP	p	G95N	0	.	.	283	285	GGC	895	897	GGC	108;108;108	G;G;C	93;95;87	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1304	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	78.6	0	HET	.	.	.	G2377A	.	2377	2377	G	2989	2989	G	67	G,A	50,7	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	496	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1748	68.0	1	SNP	p	G45D	0	.	.	133	135	GGC	665	667	GGC	110;110;110	G;G;C,A	96;92;93,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	298	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1516	46.8	0	.	n	.	0	A197.	DEL	197	197	A	810	810	A	117	A	106	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1456	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3505	99.0	1	SNP	p	D86N	0	.	.	256	258	GAC	875	877	GAC	82;81;87	G;A,C;C,A	65;50,1;67,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1456	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3505	99.0	1	SNP	p	R87W	0	.	.	259	261	CGT	878	880	CGT	86;86;88	C;G,C;T,G	72;56,1;66,2	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1456	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3505	99.0	1	SNP	p	S87R	1	.	.	259	261	CGT	878	880	CGT	86;86;88	C;G,C;T,G	72;56,1;66,2	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1456	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3505	99.0	1	SNP	p	R87I	0	.	.	259	261	CGT	878	880	CGT	86;86;88	C;G,C;T,G	72;56,1;66,2	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1456	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3505	99.0	1	SNP	p	S88P	0	.	.	262	264	TCC	881	883	TCC	88;90;91	T,G,C;C,T;C	76,2,1;80,1;82	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1146	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3302	82.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1884	1886	GGC	83;83;84	G;G;C	74;71;69	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1275	1277	GCC	147;147;147	G;C;C	140;140;141	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1278	1280	ATG	148;150;150	A;T;G,T	142;143;141,2	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1290	1292	ACC	151;152;152	A,T,C;C,A,G;C	141,1,1;143,1,1;145	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1290	1292	ACC	151;152;152	A,T,C;C,A,G;C	141,1,1;143,1,1;145	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1791	1793	ACC	121;121;120	A;C;C	107;103;109	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1845	1847	GCG	112;112;112	G;C;G,T,C	99;85;97,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1845	1847	GCG	112;112;112	G;C;G,T,C	99;85;97,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1968	1970	GGT	92;91;89	G,C;G;T,G	83,1;83;80,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1977	1979	AGC	78;78;78	A,T;G;C,T	61,1;65;60,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1132	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2516	102.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1995	1997	CCG	71;71;69	C,G;C,T;G	59,1;55,1;61	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1598	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3498	106.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1886	1888	CCG	122;122;121	C,G,T;C,G;G,C	97,1,1;105,1;80,4	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	670	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2639	61.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	1108	1108	C	59	C	46	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	781	783	CAG	125;122;122	C;A,C;G	121;116,2;118	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1291	1293	AGA	158;161;161	A;G,T;A	146;147,1;147	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1312	1314	GGT	136;136;139	G;G;T	123;126;122	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	1	SNP	p	G120K	1	.	.	358	360	AAG	1021	1023	AAG	118;118;119	A,C;A;G,C	109,2;110;106,3	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	1	SNP	p	N121D	0	.	.	361	363	AAC	1024	1026	AAC	119;119;117	A;A,T;C	110;111,1;108	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	818	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	2295	86.2	1	SNP	p	A121N	1	.	.	361	363	AAC	1024	1026	AAC	119;119;117	A;A,T;C	110;111,1;108	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3226	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5265	145.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	394	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1477	65.2	1	SNP	p	V57M	1	.	.	169	171	ATG	741	743	ATG	128;126;126	A;T;G	114;116;116	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
